Johnson & Johnson secures additional land for expansion in Cork 

Johnson & Johnson has  announced that it has completed the purchase of a property located next to its existing Innovative Medicine manufacturing facility in Ringaskiddy. 

The additional land will facilitate an expansion at the existing facility. 

The property encompasses a 16.5-acre site, which a company spokesperson said will bring Johnson & Johnson’s total footprint in Ringaskiddy to 116.5-acres. 

The site includes a 15,730sqm industrial building and extensive parking facilities. 

The company said that when fitted out, the building will provide additional office accommodation, “offering an enhanced workplace experience for employees at the existing manufacturing facility.”

Announcing the details, Dana Daneshvari, General Manager & Vice President Manufacturing Large Molecule Site, Johnson & Johnson Innovative Medicine, Ringaskiddy said the additional space “will allow us to create a dynamic workplace environment that promotes collaboration, creativity, and well-being for our team.”

Daneshvari added: “By expanding our footprint, we will be able to optimise our employee experience and enhance our ability to deliver for patients around the world.” 

The fit-out works are expected to be completed by early 2027.